Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.410
+0.070 (2.10%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 4.63M | 2.98M | - | - | | 5.21M | |
Biotechnology (Startups) Growth | 55.28% | - | - | - | | - | |
| 4.63M | 2.98M | - | - | | 5.21M | |
| 55.28% | - | - | - | | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 4.63M | 2.98M | - | - | | 5.21M | |
| 55.28% | - | - | - | | - | |
| 4.63M | 2.98M | - | - | | 5.21M | |
| 55.28% | - | - | - | | - | |
Source: S&P Global Market Intelligence.
